Skip to main content

CORRECTION article

Front. Oncol., 02 June 2023
Sec. Pharmacology of Anti-Cancer Drugs
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1228436

Corrigendum: Antiproliferative effects of the natural oxadiazine Nocuolin A are associated with impairment of mitochondrial oxidative phosphorylation

This article is a correction to:

  1. Antiproliferative Effects of the Natural Oxadiazine Nocuolin A Are Associated With Impairment of Mitochondrial Oxidative Phosphorylation

    1. Read original article
Maria Lígia Sousa,Maria Lígia Sousa1,2Marco PretoMarco Preto2Vítor VasconcelosVítor Vasconcelos1Stig Linder,Stig Linder3,4Ralph Urbatzka*Ralph Urbatzka2*
  • 1Faculty of Sciences of University of Porto, Porto, Portugal
  • 2Interdisciplinary Centre of Marine and Environmental Research, Porto, Portugal
  • 3Department of Oncology and Pathology, Cancer Centre Karolinska, Karolinska Institute, Stockholm, Sweden
  • 4Department of Medical and Health Sciences, Linköping University, Linköping, Sweden

A Corrigendum on
Antiproliferative effects of the natural oxadiazine Nocuolin A are associated with impairment of mitochondrial oxidative phosphorylation

by Sousa ML, Preto M, Vasconcelos V, Linder S and Urbatzka R (2019) Front. Oncol. 9:224. doi: 10.3389/fonc.2019.00224

In the published article, a reference in the funding statement was erroneously omitted as published. Instead of:

This research was supported by the Structured Program of R&D&I INNOVMAR—Innovation and Sustainability in the Management and Exploitation of Marine Resources (reference NORTE-01-0145-FEDER-000035, Research Line NOVELMAR), funded by the Northern Regional Operational Program (NORTE2020) through the European Regional Development Fund (ERDF). The project was additionally supported the project CYANCAN—Uncovering the cyanobacterial chemical diversity: the search for novel anticancer compounds (reference PTDC/MEDQUI/30944/2017) co-financed by NORTE 2020, Portugal 2020, and the European Union through the ERDF, and by Foundation for Science and Technology through national funds. RU was supported by the FCT postdoc grant SFRH/BPD/112287/2015 and MS by the FCT PhD grant SFRH/BD/108314/2015.

It should be:

This research was supported by the Structured Program of R&D&I INNOVMAR—Innovation and Sustainability in the Management and Exploitation of Marine Resources (reference NORTE-01-0145-FEDER-000035, Research Line NOVELMAR), funded by the Northern Regional Operational Program (NORTE2020) through the European Regional Development Fund (ERDF). The project was additionally supported the project CYANCAN—Uncovering the cyanobacterial chemical diversity: the search for novel anticancer compounds (reference PTDC/MED-QUI/30944/2017 - NORTE-01-0145-FEDER-030944) co-financed by NORTE 2020, Portugal 2020, and the European Union through the ERDF, and by Foundation for Science and Technology through national funds.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: natural products, cyanobacteria, spheroids, colon cancer, anti-cancer drugs, mitochondria, autophagy

Citation: Sousa ML, Preto M, Vasconcelos V, Linder S and Urbatzka R (2023) Corrigendum: Antiproliferative effects of the natural oxadiazine Nocuolin A are associated with impairment of mitochondrial oxidative phosphorylation. Front. Oncol. 13:1228436. doi: 10.3389/fonc.2023.1228436

Received: 24 May 2023; Accepted: 25 May 2023;
Published: 02 June 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Sousa, Preto, Vasconcelos, Linder and Urbatzka. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ralph Urbatzka, cnVyYmF0emthQGNpaW1hci51cC5wdA==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.